The FDA is undergoing a period of stabilization, as exemplified by Mikhail and Davis. Meanwhile, Seehafer has indicated that an AI revolution is on the horizon. This suggests a dual focus within the organization on maintaining current stability while anticipating and preparing for future technological shifts. AI
IMPACT Signals potential shifts in regulatory focus and preparedness for AI advancements within a key health agency.
RANK_REASON The item discusses commentary from individuals regarding the FDA's current state and future outlook on AI, rather than a direct announcement or event.
Read on Mastodon — sigmoid.social →
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →